ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 0890 • ACR Convergence 2021

    Depression Is Associated with Frailty in Systemic Lupus Erythematosus Patients: Multicenter Retrospective Analysis Using Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index

    Kichul Shin1, In Ah Choi2, Eunyoung Lee3, SE RIM CHOI4, Jina Yeo5, Yun Jong Lee6, Su-Jin Yoo7, Bong-Jin Hahm4, Jee Eun Park4, Ju Ho Lee8, Yeong-Wook Song4 and Ju Yeon Kim4, 1Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Republic of Korea, 2Chungbuk National University Hospital, Cheongju, Republic of Korea, 3Uijeongbu Eulji Medical Center, Seoul, South Korea, 4Seoul National University Hospital, Seoul, Republic of Korea, 5Gil Medical Center, Seoul, South Korea, 6Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea, 7Chungnam National University Hospital, Daejeon, Republic of Korea, 8Seoul National University Bundang Hospital, Yongin Si, Republic of Korea

    Background/Purpose: Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index (SLICC-FI) is a novel health measure in systemic lupus erythematosus (SLE) and was reported to have impact…
  • Abstract Number: 0893 • ACR Convergence 2021

    Trajectories of Depressive Symptoms in Systemic Lupus Erythematosus over 7 Years

    Seerat Chawla1, Jiandong Su2, Zahi Touma3 and Patricia Katz4, 1University of California Los Angeles, Los Angeles, CA, 2University Health Network, Toronto, ON, Canada, 3University of Toronto, Mississauga, ON, Canada, 4University of California San Francisco, San Francisco, CA

    Background/Purpose: Depression remains one of the most frequently observed psychiatric disorders in patients with SLE with a pooled prevalence of 35.0% (95% CI: 29.9%-40.3%). Nevertheless,…
  • Abstract Number: 1059 • ACR Convergence 2021

    The Association of Pain and Sleep in Relation to Depressive Symptoms Among Older Adults with Arthritis

    Uyen-Sa Nguyen1, Cameron Zielke2 and Noah Peeri3, 1University of North Texas Health Science Center, School of Public Health, Arlington, TX, 2University of Illinois-Chicago, Fort Worth, TX, 3University of North Texas Health Science Center, Fort Worth

    Background/Purpose: The primary symptom of arthritis is chronic pain which has widespread consequences on an individual’s sleep and mental health. Research suggests that sleep and…
  • Abstract Number: 1305 • ACR Convergence 2021

    Undiagnosed Depression in Axial Spondyloarthropathy and the Negative Impact on Patient Outcomes: Results of a Screening Study

    Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: Previous research in axial spondyloarthropathy(axSpA) has shown this population to have a high prevalence of depression. This co-morbidity has been previously shown to impact…
  • Abstract Number: 0119 • ACR Convergence 2021

    Worsened Depression but Improved Fatigue Were the Main Impacts of Severe Lockdown in Non- COVID Infected Australian Fibromyalgia Patients

    Benjamin Worcester1, Emma Guymer2 and Geoffrey Littlejohn2, 1Monash Health, Melbourne, Australia, 2Monash University, Melbourne, Australia

    Background/Purpose: To gauge the impact of severe COVID-19 related lockdown restrictions on the mental and physical wellbeing of Australian fibromyalgia patients and their recovery following…
  • Abstract Number: 1584 • ACR Convergence 2021

    Relation of Depressive Symptoms to Alterations in Conditioned Pain Modulation in Knee Osteoarthritis: The Multicenter Osteoarthritis Study (MOST)

    Kosaku Aoyagi1, Lisa Carlesso2, Laura Frey-Law3, Gabriela Rabasa4, Cora Lewis5, Michael Nevitt6 and Tuhina Neogi7, 1Boston University, Quincy, MA, 2McMaster University, Hamilton, ON, Canada, 3University of Iowa, Iowa City, IA, 4Boston University, Boston, MA, 5University of Alabama Birmingham, Birmingham, AL, 6University of California San Francisco, Orinda, CA, 7Boston University School of Medicine, Boston, MA

    Background/Purpose: Inefficiency of descending conditioned pain modulation (CPM) is present in 42-55% of individuals with knee osteoarthritis (OA), which can contribute to more pain and…
  • Abstract Number: 0121 • ACR Convergence 2021

    The Efficacy of Group Behavioral Activation versus Usual Treatment in Patients with Fibromyalgia and Major Depression

    Josefina Duran, Alvaro Verges, Ana Rocío Vázquez-Taboada, Matias Gonzalez and Lydia Gomez-Pérez, Pontificia Universidad Católica de Chile, Santiago, Chile

    Background/Purpose: Fibromyalgia (FM) and major depression frequently coexist. Patients with both conditions have a worse prognosis and higher disability, and their treatment options are scarce.…
  • Abstract Number: 1659 • ACR Convergence 2021

    Increased All-Cause Mortality Risk in Patients with Incident Rheumatoid Arthritis After First Antidepressant Dispensing: Results from the Nationwide DANBIO Database

    jens Pedersen1, Lei Wang2, Alma Pedersen2, Kjeld Andersen3, Claus Sørensen3 and Torkell Ellingsen4, 1Department of Medicine M, Section of Rheumatology, Svendborg Hospital, Odense University Hospital, Svendborg, Denmark, Odense, Denmark, 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Mental Health, Odense, Odense, Denmark, 4Rheumatology Research Unit, Department of Rheumatology C, Odense University Hospital, Odense, Denmark

    Background/Purpose: Depression occurs with a prevalence of about 17% (95% confidence interval (CI): 10-24) in patients with RA (1) and both disorders may share common…
  • Abstract Number: 0225 • ACR Convergence 2021

    Prevalence of Sexual Dysfunction and Depression in German Patients with Psoriasis and Psoriatic Arthritis – Results of the PIPPA Study

    Sebastian Saur1, Alexandra Schloegl2, Caroline Höppner3, Anastasia Gubar2, Katharina Meier4, Matthias Hahn2 and Jorg Henes2, 1Universtiy Hostpiatl Tübingen, Tuebingen, Germany, 2University Hospital Tuebingen, Tuebingen, Germany, 3Charite Berlin, Berlin, Germany, 4Department of Dermatology, Venereology and Allergology – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, Berlin, Germany

    Background/Purpose: As known chronic inflammatory diseases have an impact on sexuality. To date, there are only a few studies from North and Latin America which…
  • Abstract Number: 1667 • ACR Convergence 2021

    Efficacy of Plasma Phosphoethanolamine as a Biomarker for Rheumatoid Arthritis-associated Depression

    Yusuke Miwa1, Yoshiaki Ohashi2, Hajime Tomatsu3 and Yuko Mitamura4, 1Division of Rheumatology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan, 2HMT Biomedical Inc., Yokohama, Japan, 3HMT Biomedical Inc., Chuo, Japan, 4Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Shinagawa-ku, Japan

    Background/Purpose: The odds of patients with rheumatoid arthritis (RA) experiencing depression is 1.42 (95% CI: 1.3–1.5; approximately 15% of patients) compared with healthy individuals. Diagnosis…
  • Abstract Number: 0236 • ACR Convergence 2021

    Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases

    Luis Gerardo Espinosa-Banuelos1, Diana Carolina Rubio Torres2, Maria Corral2, Cassandra Skinner Taylor2, Lorena Perez-Barbosa2, Luz Fernanda Gutierrez Leal2, Abraham Yair Lujano-Negrete3, Jesus Cardenas-de La Garza2 and Dionicio Galarza-Delgado2, 1Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico, 3Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico

    Background/Purpose: Untreated perinatal anxiety symptomatology can be related to symptoms of anxiety and depression during the postpartum. The psychological bond created by the mother between…
  • Abstract Number: 1672 • ACR Convergence 2021

    Many Better, Many Worse: Mean PROMIS-29 Scores Mask Significant Shifts During COVID-19 in RA

    Susan Bartlett1, Dana DiRenzo2, Michelle Jones3 and Clifton Bingham2, 1McGill University, Montréal, QC, Canada, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins Medicine, Baltimore, MD

    Background/Purpose: Rheumatic diseases (RD) are chronic conditions that require potent immunosuppressants to control systemic inflammation. Fears associated with increased vulnerability from being on immunosuppressants plus…
  • Abstract Number: 1291 • ACR Convergence 2020

    Depressed Symptomatology Persists over Time in the Majority of Systemic Lupus Erythematosus Patients and Is Independent of Disease Activity

    Sara Kellahan1, Xinliang Huang1, Daphne Lew2, Hong Xian3, Seth Eisen1 and Alfred Kim4, 1Division of Rheumatology, Washington University in St. Louis School of Medicine, St. Louis, 2Division of Biostatistics, Washington University in St. Louis School of Medicine, St. Louis, 3Department of Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, St. Louis, 4Washington University School of Medicine, St. Louis, MO

    Background/Purpose: Depression is a prevalent (24-30%) and significant comorbidity in patients with systemic lupus erythematosus (SLE) (1).  As the American College of Rheumatology (ACR) classifies…
  • Abstract Number: 1295 • ACR Convergence 2020

    Disease Activity and Mental Health in SLE Patients: A Cross-section Study with Self-Assessments Based on Smart System of Disease Management (SSDM) Mobile Tools

    Yongfu Wang1, Hua Wei2, Rui Wu3, Jianhong Wu4, Shengtao Zhang5, Qin Li6, Yang Li7, You Sun7, Yanping Zhao8, Qiang Shu9, Lirong Kang1, Bin Wu10, Li Qin11, Feng Jiang11, Huiqin Yang12, Junli Zhang13, Hui Xiao14, Bing Wu15, Yuhua Jia15, Fei Xiao15 and Lingyun Sun16, 1The First Affiliated Hospital of BaoTou Medical College, Inner Mongolia University of Science and Technology, Baotou, China (People's Republic), 2Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 3The First Affiliated Hospital of Nanchang University, Nanchang, China (People's Republic), 4Department of Rheumatology, Dazhou Central Hospital, Dazhou, China (People's Republic), 5Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), 6The First People's Hospital of Yunnan Province, Kunming, China (People's Republic), 7The Second Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 8First Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 9Qilu Hospital of Shandong University, Jinan, China (People's Republic), 10The First People's Hospital of Jingzhou, Jingzhou, China (People's Republic), 11The No.3 People’s Hospital of HuZhou City, Huzhou, China (People's Republic), 12Wuhan No. 1 Hospital, Wuhan, China (People's Republic), 13Xi'an No. 5 Hospital, Xi'an, China (People's Republic), 14Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 15Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic), 16Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China (People's Republic)

    Background/Purpose: WHO survey showed that the prevalence of anxiety and depression in Chinese population and Chinese patients with chronic diseases were between 3.1% - 4.2%…
  • Abstract Number: 1319 • ACR Convergence 2020

    Disease Activity and Mental Health of as Patients: A Cross-section Study with Self-assessments Based on Smart System of Disease Management (SSDM) Mobile Tools

    Hui Song1, Hua Wei2, Miaojia Zhang3, Lijun Wu4, Zhenbiao Wu5, Aichun Chu6, Bei Wang7, Wenqiang Fan8, Xiaohan Wang9, Xiaoqi Chen10, Henglian Wu11, Wenyu Zhou12, Fei Xiao13, Hui Xiao14, Yuhua Jia13, Bing Wu13 and Jing Lu15, 1Beijing Jishuitan Hospital, Beijing, China (People's Republic), 2Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 3Jiangsu Province Hospital, The first affiliated hospital of Nanjing medical university, Nanjing, China (People's Republic), 4People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China (People's Republic), 5The First Affiliated Hospital of The Air Force Medical University, Xi'an, Shanxi, China (People's Republic), 6Remin Hospital of Wuhan University Hubei General Hospital, Wuhan, China (People's Republic), 7Beijing Hospital of Traditional Chinese Medicine, Beijing, China (People's Republic), 8Central Hospital of XinXiang, Xinxiang, China (People's Republic), 9Anyang district hospital, Anyang, Henan, China (People's Republic), 10Zhongnan Hospital of Wuhan University, Wuhan, China (People's Republic), 11Dongguan Donghua Hospital, Dongguan, Guangdong, China (People's Republic), 12Wuhan No. 4 Hospital, Wuhan, China (People's Republic), 13Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic), 14Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 15First Affiliated Hospital of China Medical University, Shenyang, China (People's Republic)

    Background/Purpose: WHO survey showed that the prevalence of anxiety and depression in Chinese population and Chinese patients with chronic diseases were between 3.1% - 4.2%…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology